Overview

Abatacept in the Treatment of Uveitis

Status:
Completed
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and efficacy of abatacept in the treatment of uveitis.
Phase:
Phase 2
Details
Lead Sponsor:
Oregon Health and Science University
Collaborator:
Bristol-Myers Squibb
Treatments:
Abatacept